NEX – Network of Experts

The IPOPI Network of Experts, known as IPOPI NEX, is a consultative network that provides expert advice and information to the IPOPI Board of Directors.

IPOPI NEX supports IPOPI on a voluntary and needs-driven basis. Its experts bring knowledge from a wide range of fields, including regulation, ethics, nursing, plasma access, advanced therapies, health economics, immunology and market data.

This broad expertise helps IPOPI take a multidisciplinary approach to its work. As a result, the organisation can better address complex issues that affect people living with primary immunodeficiencies.

Role of IPOPI NEX

IPOPI NEX is different from the IPOPI Medical Advisory Panel (MAP). While MAP provides clinical and scientific expertise on primary immunodeficiencies, IPOPI NEX brings complementary knowledge from other specialist areas.

In addition, IPOPI NEX is not a formal body within IPOPI’s governance structure. Instead, it acts as a flexible consultative network. This allows IPOPI to seek expert input when specific needs or projects arise.

Through this network, IPOPI can benefit from independent advice, practical insights and specialist perspectives. These contributions support IPOPI’s mission and strengthen its advocacy, policy and educational work.

IPOPI NEX experts

Dr Manuela Mura (Regulator)

Dr Peter Jawroski (Ethicist)

Nurse Mary Louise Daly (Nursing)

Professor Albert Farrugia (Plasma industry/access specialist)

Professor Bobby Gaspar (Advanced therapies industry specialist)

Professor James Taylor (Ethicist)

Professor Dr Frank Staal (Academic ATMP specialist)

Professor Dr Cornelis Boersma (Health economist)

Mr Matthew Hotchko, PhD (Plasma Industry market data specialist)

Dr Olaf Neth (Immunologist)

Professor Tandakha Dieye (Immunologist/vaccinology specialist)